9 research outputs found

    Expansion of U.S. Emergency Medical Service Routing for Stroke Care: 2000-2010

    No full text
    Introduction: Organized stroke systems of care include preferential emergency medical services (EMS) routing to deliver suspected stroke patients to designated hospitals. To characterize the growth and implementation of EMS routing of stroke nationwide, we describe the proportion of stroke hospitalizations in the United States (U.S.) occurring within regions having adopted these protocols.Methods: We collected data on ischemic stroke using International Classification of Diseases-9 (ICD-9) coding from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) database from the years 2000-2010. The NIS contains all discharge data from 1,051 hospitals located in 45 states, approximating a 20% stratified sample. We obtained data on EMS systems of care from a review of archives, reports, and interviews with state emergency medical services (EMS)  officials. A county or state was considered to be in transition if the protocol was adopted in the calendar year, with establishment in the year following transition.Results: Nationwide, stroke hospitalizations remained constant over the course of the study period: 583,000 in 2000 and 573,000 in 2010. From 2000-2003 there were no states or counties participating in the NIS with EMS systems of care. The proportion of U.S. stroke hospitalizations occurring in jurisdictions with established EMS regional systems of acute stroke care increased steadily from 2004 to 2010 (1%, 13%, 28%, 30%, 30%, 34%, 49%). In 2010, 278,538 stroke hospitalizations, 49% of all U.S. stroke hospitalizations, occurred in areas with established EMS routing, with an additional 18,979 (3%) patients in regions undergoing a transition to EMS routing.Conclusion: In 2010, a majority of stroke patients in the U.S. were hospitalized in states with established or transitioning to organized stroke systems of care. This milestone coverage of half the U.S. population is a major advance in systematic stroke care and emphasizes the need for novel approaches to further extend access to stroke center care to all patients. [West J Emerg Med. 2014;15(4):499–503.]

    Enrollment Yield and Reasons for Screen Failure in a Large Prehospital Stroke Trial

    No full text
    BACKGROUND AND PURPOSE: The enrollment yield and reasons for screen failure in prehospital stroke trials have not been well delineated. METHODS: The Field Administration of Stroke Therapy – Magnesium (FAST-MAG) trial identified patients for enrollment using a two stage screening process - paramedics in person followed by physician-investigators by cellphone. Outcomes of consecutive screening calls from paramedics to enrolling physician-investigators were prospectively recorded. RESULTS: From 2005 to 2012, 4,458 phone calls were made by paramedics to physician-investigators, an average of one call per vehicle every 135.7 days. A total of 1,700 (38.1%) calls resulted in enrollments. The rate of enrollment of stroke mimics was 3.9%. Among the 2,758 patients not enrolled, 3,140 reasons for screen failure were documented. The most common reasons for non-enrollment were: more than 2 hours from last known well (17.2%), having a prestroke condition causing disability (16.1%), and absence of a consent provider (9.5%). Novel barriers for phone informed consent specific to the prehospital setting were infrequent, but included: cellphone connection difficulties (3.2%), patient being hard of hearing (1.4%), insufficient time to complete consent (1.3%) or severely dysarthric (1.3%). CONCLUSIONS: In this large, multicenter prehospital trial, nearly 40% of every calls from the field to physician-investigators resulted in trial enrollments. The most common reasons for non-enrollment were out of window last known well time, prestroke confounding medical condition, and absence of a consent provider. CLINICAL TRIAL REGISTRATION—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00059332. Barrier to completion of prehospital phone informed consen

    Routing Ambulances to Designated Centers Increases Access to Stroke Center Care and Enrollment in Prehospital Research

    No full text
    BACKGROUND AND PURPOSE: Emergency Medical Services (EMS) routing of acute stroke patients to designated centers may increase the proportion of patients receiving care at facilities meeting national standards and augment recruitment for prehospital stroke research. METHODS: We analyzed consecutive patients enrolled within 2 hours of symptom onset in a prehospital stroke trial, before and after regional Los Angeles County Emergency Medical Services (EMS) implementation of preferentially routing acute stroke patients to Approved Stroke Centers (ASCs). From January 2005 to mid-November 2009, patients were transported to the nearest Emergency Department, while from mid-November 2009 to December 2012 patients were preferentially transported to first 9, and eventually 29, ASCs. RESULTS: There were 863 subjects enrolled before and 764 after EMS preferential routing, with implementation leading to an increase in the proportion cared for at an ASC from 10% to 91% (P<0.0001), with a slight decrease in paramedic on-scene to Emergency Department arrival time (34.5 minutes [SD 9.1] vs. 33.5 [SD 10.3], p=0.045). The effects of routing were immediate and included an increase in of proportion receiving ASC care (from 17% to 88%, p<0.001) and a greater number of enrolments (18.6% increase) when comparing 12 months before and after regional stroke system implementation. CONCLUSIONS: The establishment of a regionalized EMS system of acute stroke care dramatically increased the proportion of acute stroke patients cared for at ASCs, from 1 in 10 to more than 9 in 10, with no clinically significant increase in prehospital care times, and enhanced recruitment of patients into a prehospital treatment trial

    Environmental triggers of multiple sclerosis

    Get PDF
    Multiple sclerosis is a chronic immune-mediated disease of the central nervous system that develops in young adults with a complex genetic predisposition. Similar to other autoimmune disease, HLA-DR and -DQ alleles within the HLA class II region on chromosome 6p21 are by far the strongest risk-conferring genes. Less robust susceptibility effects have been reported for non-MHC related genetic variants. Improvements in the design of epidemiological studies helped to identify consistent environmental risk-associations such as the increased susceptibility for MS in individuals with a history of infectious mononucleosis, a symptomatic primary infection with the human γ-herpesvirus Epstein-Barr virus (EBV). Sun exposure and serum vitamin D levels are emerging non-infectious environmental risk factors that may have independent roles. The analysis of environmental effects will likely expand in the next few years and will allow for the generation of testable hypotheses as to how environmental insults interact with genetic factors to jointly determine the susceptibility to MS. Insights gained from these studies might facilitate the development of prevention strategies and more effective treatments for MS
    corecore